TickerFacts.

Iqvia Holdings Inc. (IQV): Shareholders' Equity

Annual figures by period end, from SEC filings.

$6.63B
As of 2025-12-31
$6.35B
As of 2026-03-31
+4.8%
3-year compound annual growth
+1.1%
5-year compound annual growth
$8.78B2011-12-31: -$969.60M2012-12-31: -$1.36B2013-12-31: -$667.49M2014-12-31: -$703.00M2015-12-31: -$336.00M2016-12-31: $8.78B2017-12-31: $8.24B2018-12-31: $6.95B2019-12-31: $6.26B2020-12-31: $6.28B2021-12-31: $6.04B2022-12-31: $5.76B2023-12-31: $6.11B2024-12-31: $6.07B2025-12-31: $6.63B$6.63B
2011-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31$6.63B+9.3%2026-02-17, Balance as of period end
2024-12-31$6.07B-0.7%2026-02-17, Balance as of period end
2023-12-31$6.11B+6.0%2026-02-17, Balance as of period end
2022-12-31$5.76B-4.6%2025-02-13, Balance as of period end
2021-12-31$6.04B-3.8%2024-02-15, Balance as of period end
2020-12-31$6.28B+0.3%2023-02-15, Balance as of period end
2019-12-31$6.26B-9.9%2022-02-16, Balance as of period end
2018-12-31$6.95B-15.6%2021-02-12, Balance as of period end
2017-12-31$8.24B-6.1%2020-02-18, Balance as of period end
2016-12-31$8.78Bn/m2019-02-19, Balance as of period end
2015-12-31-$336.00Mn/m2018-02-16, Balance as of period end
2014-12-31-$703.00Mn/m2017-02-16, Balance as of period end
2013-12-31-$667.49Mn/m2016-02-11, Balance as of period end
2012-12-31-$1.36Bn/m2015-02-12, Balance as of period end
2011-12-31-$969.60Mn/a2014-02-13, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Iqvia Holdings Inc. (IQV)2025-12-31$6.63B+9.3%
Icon PLC (ICLR)2025-12-31$9.19B-2.6%
Incyte Corp (INCY)2025-12-31$5.17B+49.9%
Charles River Laboratories International, Inc. (CRL)2025-12-27$3.17B-8.6%
Medpace Holdings, Inc. (MEDP)2025-12-31$459.07M-44.4%
NRC Health (NRC)2025-12-31$13.99M-55.3%
MaxCyte, Inc. (MXCT)2025-12-31$171.49M-16.9%
OmniAb, Inc. (OABI)2025-12-31$267.03M-7.2%
Foxo Technologies Inc. (FOXO)2025-12-31$11.14M+109.3%

Compare IQV, ICLR, INCY, CRL side by side · Screen every company in Services-Commercial Physical & Biological Research ↗